For instance, kidney transplant survival is poorer when the donor is African American compared to European American, but after accounting for those African American donors with the high-risk genotype, African ancestry is no longer associated with such outcomes.57–59 While stories like that of APOL1 and kidney disease are likely uncommon, other health disparities are being investigated for genomic contributions, fueled by the increasing availability of genomic data for diverse populations. Here, APOL1 is linked to kidney disorder.